Gregory Scott Duncan - 04 Dec 2025 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Issuer symbol
DWTX
Transactions as of
04 Dec 2025
Transactions value $
$0
Form type
4
Filing time
05 Dec 2025, 16:05:15 UTC
Previous filing
18 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER, Director C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA /s/ Greg Duncan 05 Dec 2025 0001831127

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DWTX Stock Option (right to buy) Award $0 +460K $0.00 460K 04 Dec 2025 Common Stock 460K $6.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on December 4, 2026 and 1/24th monthly thereafter.